AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 181 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,967,000 | +14.6% | 29,465 | -11.7% | 0.24% | +10.9% |
| Q2 2017 | $1,717,000 | -15.3% | 33,365 | -3.9% | 0.22% | -20.2% |
| Q1 2017 | $2,027,000 | +45.4% | 34,715 | +3.9% | 0.28% | +37.1% |
| Q4 2016 | $1,394,000 | -25.3% | 33,415 | -5.4% | 0.20% | -27.9% |
| Q3 2016 | $1,865,000 | +29.2% | 35,315 | +2.5% | 0.28% | +21.2% |
| Q2 2016 | $1,444,000 | +77.2% | 34,465 | +71.7% | 0.23% | +75.0% |
| Q1 2016 | $815,000 | +1.2% | 20,075 | +62.0% | 0.13% | +3.9% |
| Q4 2015 | $805,000 | -2.2% | 12,395 | +6.3% | 0.13% | -7.3% |
| Q3 2015 | $823,000 | -35.4% | 11,665 | +1.7% | 0.14% | -29.4% |
| Q2 2015 | $1,274,000 | +64.4% | 11,465 | +39.5% | 0.19% | +65.8% |
| Q1 2015 | $775,000 | +1.0% | 8,220 | +20.0% | 0.12% | -0.8% |
| Q4 2014 | $767,000 | – | 6,850 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 965,369 | $56,378,000 | 14.98% |
| Casdin Capital, LLC | 237,500 | $13,870,000 | 8.18% |
| BB BIOTECH AG | 2,839,528 | $165,828,000 | 5.42% |
| Opaleye Management Inc. | 130,000 | $7,592,000 | 3.78% |
| Redmile Group, LLC | 902,578 | $52,711,000 | 3.42% |
| Clarius Group, LLC | 109,230 | $6,379,000 | 2.63% |
| Opus Point Partners Management, LLC | 57,410 | $3,353,000 | 2.49% |
| Ghost Tree Capital, LLC | 125,000 | $7,300,000 | 1.36% |
| CAPITAL INTERNATIONAL LTD /CA/ | 346,937 | $20,261,000 | 1.32% |
| Eventide Asset Management | 300,800 | $17,567,000 | 1.16% |